Cytoprotective effect of prostacyclin on hepatic ischemia-reperfusion injury

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-3)

Tables (1-4)

Sum=39

Dec 20, 2025 (publication date) through Aug 4, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Methodology

ISSN

2222-0682

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Methodol. Dec 20, 2025; 15(4): 104472
Published online Dec 20, 2025. doi: 10.5662/wjm.v15.i4.104472

Figure 1 Main functions of the liver and how they are affected by ischemia-reperfusion injury.

Figure 2 Mechanisms of hepatic ischemia-reperfusion injury and prostacyclin effect. PGI₂: Pprostacyclin; ROS: Reactive oxygen species.

Figure 3 Simplified eicosanoids synthetic pathway and their role in hepatic ischemia-reperfusion injury.

Citation: Mouratidou C, Pavlidis ET, Katsanos G, Papaioannou M, Niti A, Kotoulas SC, Tsoulfas G, Mouloudi E, Galanis IN, Pavlidis TE. Cytoprotective effect of prostacyclin on hepatic ischemia-reperfusion injury. World J Methodol 2025; 15(4): 104472
URL: https://www.wjgnet.com/2222-0682/full/v15/i4/104472.htm
DOI: https://dx.doi.org/10.5662/wjm.v15.i4.104472